Neil Kumar received $15.6M in total compensation as Ph.D. Chief Executive Officer of BridgeBio Pharma, Inc. in FY2024. The largest component was $12.5M in stock awards. Source: SEC DEF 14A.
Executive Compensation Summary for BridgeBio Pharma, Inc.
Neil Kumar Salary and Compensation - BridgeBio Pharma, Inc. CEO Pay 2024
In fiscal year 2024, Neil Kumar, Ph.D. Chief Executive Officer of BridgeBio Pharma, Inc. (BBIO), received total compensation of $15.6 million.
Neil Kumar's compensation breakdown includes: base salary of $988K, bonus of $1.0 million, stock awards valued at $12.5 million, option awards of $1000K, and other compensation of $14K.
BridgeBio Pharma, Inc. (BBIO) Executive Pay 2024
BridgeBio Pharma, Inc.'s top 3 named executive officers received combined total compensation of $27.7 million in fiscal year 2024.
The named executive officers disclosed in BridgeBio Pharma, Inc.'s 2024 proxy statement are:Neil Kumar (Ph.D. Chief Executive Officer) with total compensation of $15.6 million, Thomas Trimarchi (Ph.D.(4) President and Chief Financial Officer) with total compensation of $6.5 million, and Brian Stephenson (Ph.D., CFA Former Chief Financial Officer) with total compensation of $5.7 million.